Article
Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India.
The Indian journal of medical research - 1 Jul 2021
Nambiar Remya, Tornheim Jeffrey A, Diricks Margo, De Bruyne Katrien, Sadani Meeta, Shetty Anjali, Rodrigues Camilla
Abstract excerpt
Background & objectives: Linezolid (LZD) is increasingly being used in tuberculosis (TB) treatment. However, LZD resistance has already been reported, which is highly alarming, given its critical therapeutic role. This study was aimed to phenotypically and genotypically assess LZD resistance in Mycobacterium tuberculosis (MTB) isolates at a laboratory in a tertiary care centre in Mumbai, India. Methods: A sample...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
